Search

Mithila Jegathesan

from Berlin, MD
Age ~47

Mithila Jegathesan Phones & Addresses

  • 101 Davis Ct, Berlin, MD 21811 (646) 246-5370
  • Shiprock, NM
  • 25 Tudor City Pl, New York, NY 10017 (212) 867-3410 (212) 661-1917
  • 81 Southgate Rd, Waterbury, CT 06708
  • 108 Rustling Reed Rd, Naugatuck, CT 06770 (203) 729-4517
  • Farmington, CT

Work

Company: Northern navajo medical center 2011 Position: Medical officer, pediatric attending physician

Education

School / High School: Columbia University- New York, NY 2007

Ranks

Certificate: American Board of Pediatrics Certification in Pediatrics

Professional Records

Medicine Doctors

Mithila Jegathesan Photo 1

Mithila Jegathesan

View page
Specialties:
Pediatrics
Work:
Three Lower Counties Community Services
305 10 St STE 104, Pocomoke City, MD 21851
(410) 957-1852 (phone), (410) 957-0152 (fax)
Education:
Medical School
University of Connecticut School of Medicine
Graduated: 2006
Conditions:
Allergic Rhinitis
Anemia
Congenital Anomalies of the Heart
Constipation
Croup
Languages:
English
Description:
Dr. Jegathesan graduated from the University of Connecticut School of Medicine in 2006. She works in Pocomoke City, MD and specializes in Pediatrics. Dr. Jegathesan is affiliated with Peninsula Regional Medical Center.
Mithila Jegathesan Photo 2

Mithila Jegathesan, New York NY

View page
Specialties:
Pediatrics
Work:
Pediatric Clinic
21 Audubon Ave, New York, NY 10032
Education:
University of Connecticut(2006)
Mithila Jegathesan Photo 3

Mithila Jegathesan, Pocomoke City MD

View page
Specialties:
Pediatrician
Address:
305 10Th St, Pocomoke City, MD 21851
Education:
University of Connecticut, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics

Resumes

Resumes

Mithila Jegathesan Photo 4

Pediatrician

View page
Location:
101 Davis Ct, Berlin, MD 21811
Industry:
Hospital & Health Care
Work:
Chesapeake Pediatrics and Adolescent Associates Pa
Pediatrician

Three Lower Counties Community Services, Inc. Sep 2013 - Nov 2017
Medical Doctor

Indian Health Service Aug 2011 - Aug 2013
Medical Officer

Morgan Stanley Children's Hospital of Ny Presbyterian Columbia University Jun 2010 - Jun 2011
Pediatric Chief Resident

Morgan Stanley Children's Hospital of New York Presbyterian Jun 2007 - Jun 2010
Pediatric Resident
Education:
Chatrapati Sahuji Maharaj Kanpur University, Kanpur 2002 - 2006
Doctor of Medicine, Doctorates, Medicine
University of Pennsylvania 1995 - 1999
Bachelors, Molecular Biology
Skills:
Board Certified
Pediatrics
Medical Education
Healthcare
Medicine
Public Health
Hospitals
Patient Safety
Clinical Research
Healthcare Management
Epidemiology
Critical Care
Mithila Jegathesan Photo 5

Mithila Jegathesan

View page
Mithila Jegathesan Photo 6

Mithila Jegathesan Shiprock, NM

View page
Work:
Northern Navajo Medical Center

2011 to 2000
Medical Officer, Pediatric Attending Physician

Columbia University Morgan Stanley
York, NY
2010 to 2011
Pediatric Chief Residency

Rockefeller University
New York, NY
1999 to 2003
Research Technician

University of Pennsylvania School of Medicine
Philadelphia, PA
1996 to 1999
Pennsylvania, Research Technician

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mithila Jegathesan
Mithila Jegathesan MD
Pediatrician
630 W 168 St, New York, NY 10032
(212) 305-7397

Publications

Us Patents

Methods For Abrogating A Cellular Immune Response

View page
US Patent:
20020004041, Jan 10, 2002
Filed:
Mar 12, 2001
Appl. No.:
09/804584
Inventors:
Matthew Albert - New York NY, US
Mithila Jegathesan - New York NY, US
Robert Darnell - Pelham NY, US
International Classification:
A61K048/00
A61K045/00
A61K031/739
A61K038/19
US Classification:
424/093210, 424/093700, 514/054000, 424/085100
Abstract:
Methods are provided for preventing a cellular immune response to a pre-selected antigen by ex vivo or in vivo methods whereby dendritic cell maturation is permitted to occur in the absence of effective CD4+ T cell help. Under these conditions, elimination of cytotoxic T cells is achieved. The methods may be used for the prophylaxis of an undesired immune response to an autoimmune disease antigen, a transplant antigen, or reducing an exaggerated immune response to a antigen.
Mithila Jegathesan from Berlin, MD, age ~47 Get Report